Skip to main content
Top
Published in: Endocrine 2/2007

01-10-2007 | Original Paper

Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways

Authors: Miri Ben-Eliezer, Moshe Phillip, Galia Gat-Yablonski

Published in: Endocrine | Issue 2/2007

Login to get access

Abstract

Leptin, the satiety hormone, has been found to affect growth-plate cartilage development. In the present study, some of the signal transduction pathways that mediate leptin signaling in the ATDC5 chondrogenic cell-line, a model for endochondral ossification, were analyzed. For this purpose, real-time PCR, Western blots and immunofluorescence techniques were used. It was found that leptin increased phosphorylation of ERK1/2, p38, and STAT3 in a time- and dose-dependent manner. Specific inhibition of STAT3 or ERK1/2, but not of P38, blocked the stimulatory effect of leptin on type X collagen mRNA levels. Moreover, leptin induced the translocation of ERK1/2 into the nucleus, as well as c-fos expression, indicating full activation of this cascade. Leptin-induced JNK phosphorylation was not observed, although leptin significantly and rapidly increased JNK protein levels and c-jun mRNA levels. In addition, ERK5 was identified in these cells, but there was no apparent effect of leptin on either its phosphorylation or protein level. The study indicates that the effects of leptin on growth-plate chondrocytes are specifically mediated through ERK1/2 and STAT3, while P38 is not essential for leptin-induced type X collagen expression. This is the first demonstration that these pathways are involved in leptin-induced growth.
Literature
1.
go back to reference Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J.M. Friedman, Nature 372, 425–432 (2002)CrossRef Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J.M. Friedman, Nature 372, 425–432 (2002)CrossRef
2.
go back to reference R.V. Lloyd, L. Jin, I. Tsumanuma, S. Vidal, K. Kovacs, E. Horvath, B.W. Scheithauer, M.E. Couce, B. Burguera, Pituitary 4, 33–47 (2001)CrossRefPubMed R.V. Lloyd, L. Jin, I. Tsumanuma, S. Vidal, K. Kovacs, E. Horvath, B.W. Scheithauer, M.E. Couce, B. Burguera, Pituitary 4, 33–47 (2001)CrossRefPubMed
5.
go back to reference G. Gat-Yablonski, T. Ben-Ari, B. Shtaif, O. Potievsky, O. Moran, R. Eshet, G. Maor, Y. Segev, M. Phillip, Endocrinology 145, 343–350 (2004)CrossRefPubMed G. Gat-Yablonski, T. Ben-Ari, B. Shtaif, O. Potievsky, O. Moran, R. Eshet, G. Maor, Y. Segev, M. Phillip, Endocrinology 145, 343–350 (2004)CrossRefPubMed
6.
go back to reference Y. Kishida, M. Hirao, N. Tamai, A. Nampei, T. Fujimoto, T. Nakase, N. Shimizu, H. Yoshikawa, A. Myoui, Bone 37, 607–621 (2005)CrossRefPubMed Y. Kishida, M. Hirao, N. Tamai, A. Nampei, T. Fujimoto, T. Nakase, N. Shimizu, H. Yoshikawa, A. Myoui, Bone 37, 607–621 (2005)CrossRefPubMed
8.
go back to reference K. Kume, K. Satomura, S. Nishisho, E. Kitaoka, K. Yamanouchi, S. Tobiume, M. Nagayama, J. Histochem. Cytochem. 50, 159–169 (2002)PubMed K. Kume, K. Satomura, S. Nishisho, E. Kitaoka, K. Yamanouchi, S. Tobiume, M. Nagayama, J. Histochem. Cytochem. 50, 159–169 (2002)PubMed
9.
go back to reference C. Shukunami, K. Ishizeki, T. Atsumi, Y. Ohta, F. Suzuki, Y. Hiraki, J. Bone Miner. Res. 12, 1174–1188 (1997)CrossRefPubMed C. Shukunami, K. Ishizeki, T. Atsumi, Y. Ohta, F. Suzuki, Y. Hiraki, J. Bone Miner. Res. 12, 1174–1188 (1997)CrossRefPubMed
10.
go back to reference T. Atsumi, Y. Miwa, K. Kimata, Y. Ikawa, Cell Differ. Dev. 30, 90–116 (1990) T. Atsumi, Y. Miwa, K. Kimata, Y. Ikawa, Cell Differ. Dev. 30, 90–116 (1990)
13.
go back to reference K. Nakamura, T. Shirai, S. Morishita, S. Uchida, K. Saeki-Miura, F. Makishima, Exp. Cell Res. 250, 351–363 (1999)CrossRefPubMed K. Nakamura, T. Shirai, S. Morishita, S. Uchida, K. Saeki-Miura, F. Makishima, Exp. Cell Res. 250, 351–363 (1999)CrossRefPubMed
14.
go back to reference M. Nakajima, Y. Negishi, H. Tanaka, K. Kawashima, Biochem. Biophys. Res. Commun. 320, 1069–1075 (2004)CrossRefPubMed M. Nakajima, Y. Negishi, H. Tanaka, K. Kawashima, Biochem. Biophys. Res. Commun. 320, 1069–1075 (2004)CrossRefPubMed
16.
17.
go back to reference C. Sufang, K. Nemoto, R. Kurose, N. Kobayashi, K. Kubo, A. Itabashi, J. Bone Miner. Res. Suppl. 15, S466 (2000) (Abstract) C. Sufang, K. Nemoto, R. Kurose, N. Kobayashi, K. Kubo, A. Itabashi, J. Bone Miner. Res. Suppl. 15, S466 (2000) (Abstract)
20.
go back to reference J. Turkson, D. Ryan, J.S. Kim, Y. Zhang, Z. Chen, E. Haura, A. Laudano, S. Sebti, A.D. Hamilton, R. Jove, J. Biol. Chem. 276, 45443–45455 (2001)CrossRefPubMed J. Turkson, D. Ryan, J.S. Kim, Y. Zhang, Z. Chen, E. Haura, A. Laudano, S. Sebti, A.D. Hamilton, R. Jove, J. Biol. Chem. 276, 45443–45455 (2001)CrossRefPubMed
21.
go back to reference T. Heinemeyer, E. Wingender, I. Reuter, H. Hermjakob, A. Kel, O. Kel, E. Ignatieva, E. Ananko, O. Podkolodnaya, F. Kolpakov, N. Podkolodny, N. Kolchanov, Nucleic Acids Res. 26, 364–370 (1998)CrossRef T. Heinemeyer, E. Wingender, I. Reuter, H. Hermjakob, A. Kel, O. Kel, E. Ignatieva, E. Ananko, O. Podkolodnaya, F. Kolpakov, N. Podkolodny, N. Kolchanov, Nucleic Acids Res. 26, 364–370 (1998)CrossRef
22.
go back to reference P.R. Young, M.M. McLaughlin, S. Kumar, S. Kassis, M.L. Doyle, D. McNulty, T.F. Gallagher, S. Fisher, P.C. McDonnell, S.A. Carr, M.J. Huddleston, G. Seibel, T.G. Porter, G.P. Livi, J.L. Adams, J.C. Lee, J. Biol. Chem. 272, 12116–12121 (1997)CrossRefPubMed P.R. Young, M.M. McLaughlin, S. Kumar, S. Kassis, M.L. Doyle, D. McNulty, T.F. Gallagher, S. Fisher, P.C. McDonnell, S.A. Carr, M.J. Huddleston, G. Seibel, T.G. Porter, G.P. Livi, J.L. Adams, J.C. Lee, J. Biol. Chem. 272, 12116–12121 (1997)CrossRefPubMed
24.
27.
28.
29.
go back to reference W. Waelput, A. Verhee, D. Broekaert, S. Eyckerman, J. Vandekerckhove, J.H. Beattie, J. Tavernier, Biochem. J. 348, 55–61 (2000)CrossRefPubMed W. Waelput, A. Verhee, D. Broekaert, S. Eyckerman, J. Vandekerckhove, J.H. Beattie, J. Tavernier, Biochem. J. 348, 55–61 (2000)CrossRefPubMed
30.
go back to reference P. Coppo, S. Flamant, V. De Mas, P. Jarrier, M. Guillier, M.L. Bonnet, C. Lacout, F. Guilhot, W. Vainchenker, A.G. Turhan, Br. J. Haematol. 134(2), 171–179 (2006)CrossRefPubMed P. Coppo, S. Flamant, V. De Mas, P. Jarrier, M. Guillier, M.L. Bonnet, C. Lacout, F. Guilhot, W. Vainchenker, A.G. Turhan, Br. J. Haematol. 134(2), 171–179 (2006)CrossRefPubMed
31.
32.
go back to reference J.B. Catterall, S. Carrere, P.J. Koshy, B.A. Degnan, W.D. Shingleton, C.E. Brinckerhoff, J. Rutter, T.E. Cawston, A.D. Rowan, Arthritis Rheum. 44, 2296–2310 (2001)CrossRefPubMed J.B. Catterall, S. Carrere, P.J. Koshy, B.A. Degnan, W.D. Shingleton, C.E. Brinckerhoff, J. Rutter, T.E. Cawston, A.D. Rowan, Arthritis Rheum. 44, 2296–2310 (2001)CrossRefPubMed
33.
go back to reference J. Hoogendam, E. Parlevliet, R. Miclea, C.W.G.M. Löwik, J.M. Wit, M. Karperien, Endocrinology 147(6), 3141–3152 (2006)CrossRefPubMed J. Hoogendam, E. Parlevliet, R. Miclea, C.W.G.M. Löwik, J.M. Wit, M. Karperien, Endocrinology 147(6), 3141–3152 (2006)CrossRefPubMed
35.
go back to reference P. Lenormand, C. Sardet, G. Pages, G. L’Allemain, A. Brunet, J. Pouyssegur, J. Cell Biol. 122, 1079–1088 (1993)CrossRefPubMed P. Lenormand, C. Sardet, G. Pages, G. L’Allemain, A. Brunet, J. Pouyssegur, J. Cell Biol. 122, 1079–1088 (1993)CrossRefPubMed
37.
go back to reference C. Ohlsson, J. Isgaard, J. Tornell, A. Nilsson, O.G. Isaksson, A. Lindahl, Acta Paediatr. Suppl 82, 33–40 (1993)CrossRefPubMed C. Ohlsson, J. Isgaard, J. Tornell, A. Nilsson, O.G. Isaksson, A. Lindahl, Acta Paediatr. Suppl 82, 33–40 (1993)CrossRefPubMed
40.
go back to reference R. Tuli, S. Tuli, S. Nandi, X. Huang, P.A. Manner, W.J. Hozack, K.G. Danielson, D.J. Hall, R.S. Tuan, J. Biol. Chem. 278, 41227–41236 (2003)CrossRefPubMed R. Tuli, S. Tuli, S. Nandi, X. Huang, P.A. Manner, W.J. Hozack, K.G. Danielson, D.J. Hall, R.S. Tuan, J. Biol. Chem. 278, 41227–41236 (2003)CrossRefPubMed
41.
go back to reference C.R. Chu, L.D. Kaplan, F.H. Fu, L.S. Crossett, R.K. Studer, Am. J. Sports Med. 32, 191–196 (2004)CrossRefPubMed C.R. Chu, L.D. Kaplan, F.H. Fu, L.S. Crossett, R.K. Studer, Am. J. Sports Med. 32, 191–196 (2004)CrossRefPubMed
42.
go back to reference D.J. Papachristou, P. Pirttiniemi, T. Kantomaa, A.G. Papavassiliou, E.K. Basdra, Histochem. Cell Biol. 124, 215–223 (2005)CrossRefPubMed D.J. Papachristou, P. Pirttiniemi, T. Kantomaa, A.G. Papavassiliou, E.K. Basdra, Histochem. Cell Biol. 124, 215–223 (2005)CrossRefPubMed
43.
46.
go back to reference S. Gebhard, E. Poschl, S. Riemer, E. Bauer, T. Hattori, H. Eberspaecher, Z. Zhang, V. Lefebvre, B. de Crombrugghe, K. von der Mark, Matrix Biol. 23, 309–322 (2004)CrossRefPubMed S. Gebhard, E. Poschl, S. Riemer, E. Bauer, T. Hattori, H. Eberspaecher, Z. Zhang, V. Lefebvre, B. de Crombrugghe, K. von der Mark, Matrix Biol. 23, 309–322 (2004)CrossRefPubMed
47.
go back to reference S. Murakami, G. Balmes, S. McKinney, Z. Zhang, D. Givol, B. de Crombrugghe, Genes Dev. 18, 290–305 (2004)CrossRefPubMed S. Murakami, G. Balmes, S. McKinney, Z. Zhang, D. Givol, B. de Crombrugghe, Genes Dev. 18, 290–305 (2004)CrossRefPubMed
48.
49.
go back to reference Y. Takahashi, Y. Okimura, I. Mizuno, K. Iida, T. Takahashi, H. Kaji, H. Abe, K. Chihara, J. Biol. Chem. 272, 12897–12900 (1997)CrossRefPubMed Y. Takahashi, Y. Okimura, I. Mizuno, K. Iida, T. Takahashi, H. Kaji, H. Abe, K. Chihara, J. Biol. Chem. 272, 12897–12900 (1997)CrossRefPubMed
50.
51.
Metadata
Title
Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways
Authors
Miri Ben-Eliezer
Moshe Phillip
Galia Gat-Yablonski
Publication date
01-10-2007
Publisher
Springer US
Published in
Endocrine / Issue 2/2007
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-007-9025-y

Other articles of this Issue 2/2007

Endocrine 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine